Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inner mitochondrial membrane peptidase subunit 1 (IMMP1L) is an enzyme located in the inner membrane of mitochondria. IMMP1L acts as a catalytic subunit of the mitochondrial inner membrane peptidase (IMP) complex, which is responsible for the proteolytic cleavage of mitochondrial targeting sequences from precursor proteins imported into the mitochondrial intermembrane space. This processing is critical for the maturation and function of various nuclear-encoded mitochondrial proteins. The IMP complex in humans comprises two catalytic subunits, IMMP1L and IMMP2L. IMMP1L is highly conserved and structurally related to yeast Imp1. While IMMP1L’s biochemical role is presumed to be vital for mitochondrial protein maturation, current evidence does not identify it as a direct disease gene or drug target. Deletions encompassing IMMP1L have been observed in chromosomal rearrangements linked to ocular developmental disorders, but pathogenic effects are primarily attributed to regulatory disruption of neighboring critical genes such as PAX6.
Not applicable. There is no known drug mechanism targeting IMMP1L.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inner mitochondrial membrane peptidase subunit 1 (IMMP1L).